|
| |
BioPortfolio's Approved Drugs DatabaseEloxatinOxaliplatinDownload PDF containing detailed information.
Press Releases About Eloxatin:
|
 |
| Sanofi-aventis Delivers a Solid Performance in Third Quarter 2009 |
30th October, 2009 |
sanofi-aventis |
2009 Q3 Change Change at 2009 Change Change at
on a constant 9 months on a constant
reported
|
| Hospira Launches Generic Oxaliplatin Injection |
11th August, 2009 |
Hospira, Inc. |
LAKE FOREST, Ill., Aug. 11 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, today announced U.S. Food and Drug Administration (FDA) approval
|
| Sanofi-aventis Announces Second Quarter 2009 Results |
29th July, 2009 |
sanofi-aventis |
-- Strong growth from Lantus(R) (up 26.0%), Lovenox(R) (up 13.3%) and
Taxotere(R) (up 10.7%). Further dynamism in the worldwide presence of
Plavix(R) (up 9.6%)
-- Growth
|
| Access Pharmaceuticals Provides Update on ProLindac(TM) Phase 2 Ovarian Cancer Trial and Clinical Development Plan |
1st June, 2009 |
Access Pharmaceuticals, Inc. |
ProLindac Showing High DACH Platinum Activity; Drug Well Tolerated With No Signs of Acute Neurotoxicity
DALLAS, June 1 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (http://www.accesspharma
|
| Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer |
1st June, 2009 |
Keryx Biopharmaceuticals, Inc. |
KRX-0401 + Capecitabine More Than Doubles Time to Progression and Overall Response Rate as well as Extends Overall Survival vs. Capecitabine + Placebo in Patients with 2nd or 3rd Line Metastatic
|
Companies working in the area of Eloxatin from Bioportfolio's Biocorporate database : | |
| Company Name | |
Access Pharmaceuticals is an emerging biotechnology company focused on the development and commercialization of products using the companies targeted delivery systems to improve clinical outcomes for...
www.accesspharma.com/ View full profile
| |
This page has been viewed 25 times
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Eloxatin across BioPortfolio, or for Eloxatin Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|
